Results 151 to 160 of about 38,559 (244)

Investigating Emotional Reactivity in Experienced Users of Psychedelics: A Cross-Sectional fMRI Study. [PDF]

Hum Brain Mapp
Orłowski P, Domagalik A, Bola M.
europepmc   +1 more source

A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations. [PDF]

Ther Adv Psychopharmacol
Deutsch A, Contreras LE, Kratina S, Mayo LM.   +3 more
europepmc   +1 more source

Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counseling. [PDF]

Ther Adv Drug Saf
Albert OM, Arthur A.
europepmc   +1 more source

THE MUSEUMS OF BRANDING [PDF]

, 2008
Haensch, C.-A., Isenmann, S., Knosalla, M., Weis, Joachim   +3 more
core   +1 more source

Trends in the psychedelic renaissance: applying artificial intelligence to measure media portrayal of psychedelic drugs in the 21st century. [PDF]

BJPsych Open
Bender DA, Dunn HM, Pekau A, Mohite AD, Anandarajah A, Ross BD, Steinle J, Shankar S, Kiley B, Martin S, Gonuguntla R, Stonov M, Pippala N, Abdalla R, Stille MK, Yusuf J, Villalba M, Werner G, Divekar A, Daniels-Tineo M, Wang H, Chertock S, Sharma S, Ahmed SA, Bandyopadhyay R, Sridhar J, Iyer M, Adeyemi A, Smart K, Jalil U, Alam Z, Ercal BC, Hellerstein DJ, Nemeroff CB.   +33 more
europepmc   +1 more source

<i>N</i>,<i>N</i>-Diisopropyltryptamine and diptogenia: proposed mechanisms for a frequency-selective pitch-distorting psychedelic. [PDF]

Brain Commun
Hurst A, Bajo VM.
europepmc   +1 more source

Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteers. [PDF]

BMJ Open
McAlpine R, Jaglinska M, Jedlovszky K, Kuc J, Castro A, Piot A, Timmermann C, Skipper JI, Sacchet MD, Kamboj SK.   +9 more
europepmc   +1 more source

Excusing Psychedelics and Accommodating Psychedelics

The American Journal of Bioethics
openaire   +2 more sources

Adverse outcomes following psychedelic use in adolescents and adults: associations with age and personality traits. [PDF]

Child Adolesc Psychiatry Ment Health
Sjöström D, Claesdotter-Knutsson E, Kajonius P.   +2 more
europepmc   +1 more source

Editorial: Psychedelic substances and neurological diseases: from basics to clinical application. [PDF]

Front Pharmacol
Linardi A, Caetano AL, Ureshino RP.
europepmc   +1 more source